Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00305344 · ClinicalTrials.gov registry record · Phase 1
Umbilical Cord Blood Infusion to Treat Type 1 Diabetes
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT00305344 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 23 participants.
The verdict
NCT00305344, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
While this study is now completely enrolled, we do hope to develop a "next generation" cord blood based study sometime in early 2009. Please continue to contact us if you have a child with newly diagnosed Type 1 Diabetes (T1D) who alo has their OWN cord blood in storage.
Interventions
- PROCEDURE Autologous Umbilical Cord Blood Transfusion
- BIOLOGICAL Cord blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2005-04 |
| Est. Completion | 2011-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00305344
The ClinicalTrials.gov registry entry for NCT00305344 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Autologous Umbilical Cord Blood Transfusion is the first listed.
NCT00305344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00305344 about?
NCT00305344 is a clinical study titled "Umbilical Cord Blood Infusion to Treat Type 1 Diabetes". While this study is now completely enrolled, we do hope to develop a "next generation" cord blood based study sometime in early 2009. Please continue to contact us if you have a child with newly diagnosed Type 1 Diabetes (T1D) who alo has their OWN cord blood in storage.
What is the current status of trial NCT00305344?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2005-04. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00305344?
The interventions under investigation include: Autologous Umbilical Cord Blood Transfusion (PROCEDURE), Cord blood (BIOLOGICAL).
Who is sponsoring clinical trial NCT00305344?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.